DDX53

DDX53
Available structures PDB Human UniProt search: PDBe RCSB List of PDB id codes 3IUY
Identifiers
Aliases	DDX53 , CAGE, CT26, DEAD-box helicase 53
External IDs	HomoloGene: 85175; GeneCards: DDX53; OMA:DDX53 - orthologs
Gene location (Human) Chr. X chromosome (human) [1] Band Xp22.11 Start 22,999,960 bp [1] End 23,003,589 bp [1]
RNA expression pattern Bgee Human Mouse (ortholog) Top expressed in gonad testicle sperm right testis left testis human musculoskeletal system muscular system skeletal muscle lower limb muscles muscle of leg n/a More reference expression data BioGPS n/a
Gene ontology Molecular function ATP binding hydrolase activity nucleotide binding nucleic acid binding helicase activity RNA binding Cellular component nucleus nucleolus cytoplasm Biological process RNA secondary structure unwinding Sources:Amigo / QuickGO
Orthologs Species Human Mouse Entrez 168400 n/a Ensembl ENSG00000184735 n/a UniProt Q86TM3 n/a RefSeq (mRNA) NM_182699 n/a RefSeq (protein) NP_874358 n/a Location (UCSC) Chr X: 23 – 23 Mb n/a PubMed search [2] n/a
Wikidata
View/Edit Human

DEAD-box helicase 53 is a protein that in humans is encoded by the DDX53 gene. ^[3]

Function

This intronless gene encodes a protein which contains several domains found in members of the DEAD-box helicase protein family. Other members of this protein family participate in ATP-dependent RNA unwinding. In 2024 it was found that variants of DDX53 is linked to Autism ^[4]

References

1. GRCh38: Ensembl release 89: ENSG00000184735 – Ensembl, May 2017
2. "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
3. "Entrez Gene: DEAD-box helicase 53" . Retrieved 2017-08-18.
4. genetic-discovery-reveals-direct-link-to-autism-key-player

Further reading

• Cho B, Lim Y, Lee DY, Park SY, Lee H, Kim WH, Yang H, Bang YJ, Jeoung DI (2002). "Identification and characterization of a novel cancer/testis antigen gene CAGE". Biochem. Biophys. Res. Commun. 292 (3): 715–26. doi:10.1006/bbrc.2002.6701. PMID   11922625.
• Cho B, Lee H, Jeong S, Bang YJ, Lee HJ, Hwang KS, Kim HY, Lee YS, Kang GH, Jeoung DI (2003). "Promoter hypomethylation of a novel cancer/testis antigen gene CAGE is correlated with its aberrant expression and is seen in premalignant stage of gastric carcinoma". Biochem. Biophys. Res. Commun. 307 (1): 52–63. doi:10.1016/s0006-291x(03)01121-5. PMID   12849980.
• Shim H, Lee H, Jeoung D (2006). "Cancer/testis antigen cancer-associated gene (CAGE) promotes motility of cancer cells through activation of focal adhesion kinase (FAK)". Biotechnol. Lett. 28 (24): 2057–63. doi:10.1007/s10529-006-9190-8. PMID   17028776. S2CID   7168043.
• Lee TS, Kim JW, Kang GH, Park NH, Song YS, Kang SB, Lee HP (2006). "DNA hypomethylation of CAGE promotors in squamous cell carcinoma of uterine cervix". Ann. N. Y. Acad. Sci. 1091 (1): 218–24. Bibcode:2006NYASA1091..218L. doi:10.1196/annals.1378.068. PMID   17341616. S2CID   28013856.
• Kim Y, Jeoung D (2008). "Role of CAGE, a novel cancer/testis antigen, in various cellular processes, including tumorigenesis, cytolytic T lymphocyte induction, and cell motility". J. Microbiol. Biotechnol. 18 (3): 600–10. PMID   18388483.
• Pinto D, Pagnamenta AT, Klei L, Anney R, Merico D, Regan R, Conroy J, Magalhaes TR, Correia C, Abrahams BS, Almeida J, Bacchelli E, Bader GD, Bailey AJ, Baird G, Battaglia A, Berney T, Bolshakova N, Bölte S, Bolton PF, Bourgeron T, Brennan S, Brian J, Bryson SE, Carson AR, Casallo G, Casey J, Chung BH, Cochrane L, Corsello C, Crawford EL, Crossett A, Cytrynbaum C, Dawson G, de Jonge M, Delorme R, Drmic I, Duketis E, Duque F, Estes A, Farrar P, Fernandez BA, Folstein SE, Fombonne E, Freitag CM, Gilbert J, Gillberg C, Glessner JT, Goldberg J, Green A, Green J, Guter SJ, Hakonarson H, Heron EA, Hill M, Holt R, Howe JL, Hughes G, Hus V, Igliozzi R, Kim C, Klauck SM, Kolevzon A, Korvatska O, Kustanovich V, Lajonchere CM, Lamb JA, Laskawiec M, Leboyer M, Le Couteur A, Leventhal BL, Lionel AC, Liu XQ, Lord C, Lotspeich L, Lund SC, Maestrini E, Mahoney W, Mantoulan C, Marshall CR, McConachie H, McDougle CJ, McGrath J, McMahon WM, Merikangas A, Migita O, Minshew NJ, Mirza GK, Munson J, Nelson SF, Noakes C, Noor A, Nygren G, Oliveira G, Papanikolaou K, Parr JR, Parrini B, Paton T, Pickles A, Pilorge M, Piven J, Ponting CP, Posey DJ, Poustka A, Poustka F, Prasad A, Ragoussis J, Renshaw K, Rickaby J, Roberts W, Roeder K, Roge B, Rutter ML, Bierut LJ, Rice JP, Salt J, Sansom K, Sato D, Segurado R, Sequeira AF, Senman L, Shah N, Sheffield VC, Soorya L, Sousa I, Stein O, Sykes N, Stoppioni V, Strawbridge C, Tancredi R, Tansey K, Thiruvahindrapduram B, Thompson AP, Thomson S, Tryfon A, Tsiantis J, Van Engeland H, Vincent JB, Volkmar F, Wallace S, Wang K, Wang Z, Wassink TH, Webber C, Weksberg R, Wing K, Wittemeyer K, Wood S, Wu J, Yaspan BL, Zurawiecki D, Zwaigenbaum L, Buxbaum JD, Cantor RM, Cook EH, Coon H, Cuccaro ML, Devlin B, Ennis S, Gallagher L, Geschwind DH, Gill M, Haines JL, Hallmayer J, Miller J, Monaco AP, Nurnberger JI, Paterson AD, Pericak-Vance MA, Schellenberg GD, Szatmari P, Vicente AM, Vieland VJ, Wijsman EM, Scherer SW, Sutcliffe JS, Betancur C (2010). "Functional impact of global rare copy number variation in autism spectrum disorders". Nature. 466 (7304): 368–72. Bibcode:2010Natur.466..368P. doi:10.1038/nature09146. PMC   3021798 . PMID   20531469.
• Kim Y, Park H, Park D, Lee YS, Choe J, Hahn JH, Lee H, Kim YM, Jeoung D (2010). "Cancer/testis antigen CAGE exerts negative regulation on p53 expression through HDAC2 and confers resistance to anti-cancer drugs". J. Biol. Chem. 285 (34): 25957–68. doi: 10.1074/jbc.M109.095950 . PMC   2923988 . PMID   20534591.
• Kim Y, Kim H, Park D, Han M, Lee H, Lee YS, Choe J, Kim YM, Jeoung D (2016). "miR-217 and CAGE form feedback loop and regulates the response to anti-cancer drugs through EGFR and HER2". Oncotarget. 7 (9): 10297–321. doi:10.18632/oncotarget.7185. PMC   4891121 . PMID   26863629.
• Kim H, Kim Y, Goh H, Jeoung D (2016). "Histone Deacetylase-3/CAGE Axis Targets EGFR Signaling and Regulates the Response to Anti-Cancer Drugs". Mol. Cells. 39 (3): 229–41. doi:10.14348/molcells.2016.2244. PMC   4794605 . PMID   26883907.

This article incorporates text from the United States National Library of Medicine, which is in the public domain.